China approves brain-computer interface devices, accelerates BCI race vs Musk

China's health regulators have approved multiple brain-computer interface (BCI) products this year, signaling accelerated state-backed commercialization. Beijing is providing policy support to help domestic firms compete with Elon Musk's Neuralink, aiming for global leadership in BCI technology. The approvals mark a concrete step in China's push to leapfrog in this emerging field, though clinical efficacy and long-term safety remain unproven.